You have read all your free articles, to continue reading subscribe to read the rest of this content.
BioInvent International announced on July 1st that it has further extended the research term under its cancer immunotherapy research collaboration and license agreement with Pfizer until the end of 2020. In December 2016, the companies entered into the agreement for the development and commercialAlready a subscriber Login You have read…
Under the terms of the agreement, Affibody will receive a $10 million upfront payment and is eligible to receive up to $215.5 million in additional regulatory and sales milestones, plus royalties on sales in Inmagene’s commercialization territory. Affibody and Inmagene Biopharmaceuticals have aAlready a subscriber Login You have read all…
Mitochondrial medicine company Neurovive Pharmaceutical recently announced the signing of a collaboration agreement with Isomerase Therapeutics. The agreement involves the product development and commercialization of the cyclophilin-inhibiting molecules that were recently acquired from Biotica LtAlready a subscriber Login You have read all your free articles, to continue reading subscribe to…
Uppsala Innovation Centre (UIC) has signed an agreement with the newly established Turku Life Science accelerator, the first Finnish accelerator with a life science focus. The aim with the collaboration is to increase the possibilities for synergies, business and knowledge exchange betwwen companAlready a subscriber Login You have read all…
